Literature DB >> 32017012

Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK.

T Woodcock1, P Barker2, S Daniel3, S Fletcher4, J A H Wass5, J W Tomlinson6, U Misra7, M Dattani8,9, W Arlt10, A Vercueil11.   

Abstract

These guidelines aim to ensure that patients with adrenal insufficiency are identified and adequately supplemented with glucocorticoids during the peri-operative period. There are two major categories of adrenal insufficiency. Primary adrenal insufficiency is due to diseases of the adrenal gland (failure of the hormone-producing gland), and secondary adrenal insufficiency is due to deficient adrenocorticotropin hormone secretion by the pituitary gland, or deficient corticotropin-releasing hormone secretion by the hypothalamus (failure of the regulatory centres). Patients taking physiological replacement doses of corticosteroids for either primary or secondary adrenal insufficiency are at significant risk of adrenal crisis and must be given stress doses of hydrocortisone during the peri-operative period. Many more patients other than those with adrenal and hypothalamic-pituitary causes of adrenal failure are receiving glucocorticoids as treatment for other medical conditions. Daily doses of prednisolone of 5 mg or greater in adults and 10-15 mg.m-2 hydrocortisone equivalent or greater in children may result in hypothalamo-pituitary-adrenal axis suppression if administered for 1 month or more by oral, inhaled, intranasal, intra-articular or topical routes; this chronic administration of glucocorticoids is the most common cause of secondary adrenal suppression, sometimes referred to as tertiary adrenal insufficiency. A pragmatic approach to adrenal replacement during major stress is required; considering the evidence available, blanket recommendations would not be appropriate, and it is essential for the clinician to remember that adrenal replacement dosing following surgical stress or illness is in addition to usual steroid treatment. Patients with previously undiagnosed adrenal insufficiency sometimes present for the first time following the stress of surgery. Anaesthetists must be familiar with the symptoms and signs of acute adrenal insufficiency so that inadequate supplementation or undiagnosed adrenal insufficiency can be detected and treated promptly. Delays may prove fatal.
© 2020 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists.

Entities:  

Keywords:  adrenal insufficiency; glucocorticoids; guidelines; peri-operative medicine; surgical stress

Mesh:

Substances:

Year:  2020        PMID: 32017012     DOI: 10.1111/anae.14963

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  13 in total

Review 1.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

Review 2.  Perioperative management of the child with asthma.

Authors:  S Bali; S Seglani; J Challands
Journal:  BJA Educ       Date:  2022-09-10

3.  Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).

Authors:  Tomohiro Ishii; Kenichi Kashimada; Naoko Amano; Kei Takasawa; Akari Nakamura-Utsunomiya; Shuichi Yatsuga; Tokuo Mukai; Shinobu Ida; Mitsuhisa Isobe; Masaru Fukushi; Hiroyuki Satoh; Kaoru Yoshino; Michio Otsuki; Takuyuki Katabami; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2022-04-10

4.  Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice.

Authors:  Puja Mehta; Karim Meeran; Elizabeth Macphie; Afroze Abbas; Jonathan Rippin; Rachel C Jeffery; Venkat Reddy; Maria J Leandro; Coziana Ciurtin; Helen L Simpson; Sarah L Mackie
Journal:  Lancet Rheumatol       Date:  2020-12-03

5.  Case Report: Late-Onset Congenital Adrenal Hyperplasia and Acute Covid-19 Infection in a Pregnant Woman: Multidisciplinary Management.

Authors:  Claudia Giavoli; Enrico Iurlaro; Valentina Morelli; Giulia Rodari; Andrea Ronchi; Carlo Pietrasanta; Lorenza Pugni; Daniela Tubiolo; Paolo Properzi; Antonio Pesenti; Giovanna Mantovani; Enrico Ferrazzi; Maura Arosio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-15       Impact factor: 5.555

Review 6.  Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice.

Authors:  Katarzyna Pelewicz; Piotr Miśkiewicz
Journal:  Diagnostics (Basel)       Date:  2021-04-20

7.  Guidance for the prevention and emergency management of adult patients with adrenal insufficiency.

Authors:  Helen Simpson; Jeremy Tomlinson; John Wass; John Dean; Wiebke Arlt
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

8.  Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.

Authors:  Alessandro Prete; Angela E Taylor; Irina Bancos; David J Smith; Mark A Foster; Sibylle Kohler; Violet Fazal-Sanderson; John Komninos; Donna M O'Neil; Dimitra A Vassiliadi; Christopher J Mowatt; Radu Mihai; Joanne L Fallowfield; Djillali Annane; Janet M Lord; Brian G Keevil; John A H Wass; Niki Karavitaki; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

Review 9.  Pediatric Adrenal Insufficiency: Challenges and Solutions.

Authors:  Daniela Nisticò; Benedetta Bossini; Simone Benvenuto; Maria Chiara Pellegrin; Gianluca Tornese
Journal:  Ther Clin Risk Manag       Date:  2022-01-11       Impact factor: 2.423

Review 10.  Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective.

Authors:  Kim M J A Claessen; Cornelie D Andela; Nienke R Biermasz; Alberto M Pereira
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.